Genmab (GMAB DC) sees FY profit between USD 3.81-4.11bln, sees FY EBIT between USD 0.9-1.4bln; sees FY operating expenses between USD 2.71-2.91bln
Importance
Level 1
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#FOREX#METALS#EU SESSION#US SESSION#METALS & MINING#DXY#EUROPEAN EQUITIES